Quest Diagnostics Incorporated
DGX
Pozycja w akcjach
#933
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Cena akcji
$234.71
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$25.91B
Zmiana (1 dzień)
-1.76%
Zmiana (1 rok)
23.85%
Kraj
US
Handel Quest Diagnostics Incorporated (DGX)
Kategoria
Healthcare
EPS dla Quest Diagnostics Incorporated (DGX)
EPS na dzień June 2026 TTM: $9.54
Według najnowszych raportów finansowych i ceny akcji firmy Quest Diagnostics Incorporated, obecny EPS (TTM) wynosi $9.54. Na koniec roku 2024 firma miała EPS w wysokości $7.80, wzrost w porównaniu do do EPS z roku 2023, który wynosił $7.59.
Historia EPS dla Quest Diagnostics Incorporated od 2000 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $9.54 | 7.55% |
| 2025 | $8.87 | 13.72% |
| 2024 | $7.80 | 2.77% |
| 2023 | $7.59 | -6.53% |
| 2022 | $8.12 | -48.93% |
| 2021 | $15.90 | 48.88% |
| 2020 | $10.68 | 67.40% |
| 2019 | $6.38 | 17.93% |
| 2018 | $5.41 | -3.91% |
| 2017 | $5.63 | 22.93% |
| 2016 | $4.58 | -6.91% |
| 2015 | $4.92 | 28.46% |
| 2014 | $3.83 | -31.36% |
| 2013 | $5.58 | 59.89% |
| 2012 | $3.49 | 18.31% |
| 2011 | $2.95 | -27.70% |
| 2010 | $4.08 | 4.35% |
| 2009 | $3.91 | 30.77% |
| 2008 | $2.99 | 69.89% |
| 2007 | $1.76 | -40.94% |
| 2006 | $2.98 | 9.96% |
| 2005 | $2.71 | 10.61% |
| 2004 | $2.45 | 16.11% |
| 2003 | $2.11 | 26.35% |
| 2002 | $1.67 | 91.95% |
| 2001 | $0.87 | 52.63% |
| 2000 | $0.57 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $18.62 | 95.18% |
US
|
|
| $5.65 | -40.78% |
US
|
|
| $-1.36 | -114.26% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -46.65% |
US
|
